Skip to content
SEKISUI XenoTech DD Blog Logo

Meet the Scientist: Darina Hynes

Dr. Darina Hynes obtained her Ph.D. in Molecular Medicine from the Royal College of Surgeons in Ireland. She is currently a Business Development Manager facilitating access to high-quality drug metabolism and pharmacokinetics (DMPK) studies and drug-drug interaction (DDI) consulting services to clients in Europe, but that isn’t where she began her career with SEKISUI. Darina has been with SEKISUI Medical since 2008, starting as a research scientist before transitioning to the Business Development team.

Darina reflected on her journey: “SEKISUI is a household name in Japan for housing and plastics but has also expanded into the medical field and drug safety testing. In this article, I share my story with emphasis on the connection between Japan and Europe and insight into SEKISUI’s international expansion.

In 2008, I was accepted into the Overseas Graduate Program run by the Irish government after my PhD studies to take up a placement as a research scientist at SEKISUI Medical Co. Ltd. The laboratory is located in the Ibaraki prefecture. My research included gene expression discovery of key drug metabolizing enzymes using microarray technology. We were always encouraged to present at national and international scientific meetings, which in addition to collaborating with Japanese scientists, I was granted opportunities to travel and form relationships in Japan. A highlight was an invited speaker opportunity at Nagasaki University from Professor Nakashima.

Since 2012, I have been working for SEKISUI XenoTech in Europe as the Business Development Manager for European customers. It has been exciting to be part of SEKISUI’s growth and establishing market presence in Europe. SEKISUI XenoTech serves an international client base and, along with my team, we are responsible for helping clients in Europe achieve their drug development needs according to the regulatory agencies in Europe (EMA), USA (FDA) and Japan (PMDA). As a company, we are in the position of not only building a strong relationship between Japan and Europe, but as our laboratory is headquartered in the United States, I like to think we are a triangle or tripod of global harmony.

We are working hard to build on brand awareness and share our vision for a healthier tomorrow, with our mission to improve the health and welfare of society and future generations by supporting the development of life-enhancing therapies and values for our European customers and beyond.”

Contact Darina if you are located in Europe and would like her insights on meeting regulatory expectations and gathering reliable data on your drugs’ pharmacokinetic profile.

About the Authors

Darina Hynes, Ph.D. is a Business Development Manager providing premier access to high-quality drug metabolism and pharmacokinetics (DMPK) studies and drug-drug interaction (DDI) consulting services to clients in the European Union. Darina obtained her Ph.D. in Molecular Medicine from the Royal College of Surgeons in Ireland. She has been with SEKISUI Medical since 2008, beginning as a research scientist studying hepatotoxicity and eventually transitioning to the Business Development team. Since 2012, she has been helping pharmaceutical and biotechnology clients in the EU meet regulatory expectations and gather reliable data for their drugs' pharmacokinetic profile.

Building a reputation for excellence

We are proud to have some of the brightest minds in DDI & DMPK research in our labs. Browse our new Meet Our Experts page where you can find bios for some of our most seasoned scientists working on both Contract Research & Test Systems teams.

Team of DMPK researchers

Read more about the research performed at SEKIUI XenoTech

Access ADME™ is our all-inclusive repository for scientific resources. Find scientific posters, publications, blog posts, webinars and more relating to ADME/DMPK, drug-drug interactions and other studies.

Access ADME